120 related articles for article (PubMed ID: 30265884)
1. Value of MR-US fusion in guidance of repeated prostate biopsy in men with PSA < 10 ng/mL.
Hwang SI; Lee HJ; Lee SE; Hong SK; Byun SS; Lee SC; Choe G
Clin Imaging; 2019; 53():1-5. PubMed ID: 30265884
[TBL] [Abstract][Full Text] [Related]
2. [Detection of prostate cancer by real-time MR/ultrasound fusion-guided biopsy: 3T MRI and state of the art sonography].
Durmus T; Stephan C; Grigoryev M; Diederichs G; Saleh M; Slowinski T; Maxeiner A; Thomas A; Fischer T
Rofo; 2013 May; 185(5):428-33. PubMed ID: 23420313
[TBL] [Abstract][Full Text] [Related]
3. [Multiparametric MRI and MRI-TRUS fusion biopsy in patients with prior negative prostate biopsy].
Kesch C; Radtke JP; Distler F; Boxler S; Klein T; Hüttenbrink C; Hees K; Roth W; Roethke M; Schlemmer HP; Hohenfellner M; Hadaschik BA
Urologe A; 2016 Aug; 55(8):1071-7. PubMed ID: 27168038
[TBL] [Abstract][Full Text] [Related]
4. The value of magnetic resonance imaging and ultrasonography (MRI/US)-fusion biopsy platforms in prostate cancer detection: a systematic review.
Gayet M; van der Aa A; Beerlage HP; Schrier BP; Mulders PF; Wijkstra H
BJU Int; 2016 Mar; 117(3):392-400. PubMed ID: 26237632
[TBL] [Abstract][Full Text] [Related]
5. Reduced Core Targeted (RCT) biopsy: Combining multiparametric magnetic resonance imaging - transrectal ultrasound fusion targeted biopsy with laterally-directed sextant biopsies - An alternative template for prostate fusion biopsy.
Aminsharifi A; Gupta RT; Tsivian E; Sekar S; Sze C; Polascik TJ
Eur J Radiol; 2019 Jan; 110():7-13. PubMed ID: 30599876
[TBL] [Abstract][Full Text] [Related]
6. Poor reproducibility of PIRADS score in two multiparametric MRIs before biopsy in men with elevated PSA.
Müller S; Lilleaasen G; Sand TE; Løfsgaard L; Estop-Garanto M; Helgø D; Sund P; Mygland V
World J Urol; 2018 May; 36(5):687-691. PubMed ID: 29508048
[TBL] [Abstract][Full Text] [Related]
7. In patients with a previous negative prostate biopsy and a suspicious lesion on magnetic resonance imaging, is a 12-core biopsy still necessary in addition to a targeted biopsy?
Salami SS; Ben-Levi E; Yaskiv O; Ryniker L; Turkbey B; Kavoussi LR; Villani R; Rastinehad AR
BJU Int; 2015 Apr; 115(4):562-70. PubMed ID: 25252133
[TBL] [Abstract][Full Text] [Related]
8. Prostate cancer diagnosis: multiparametric MR-targeted biopsy with cognitive and transrectal US-MR fusion guidance versus systematic biopsy--prospective multicenter study.
Puech P; Rouvière O; Renard-Penna R; Villers A; Devos P; Colombel M; Bitker MO; Leroy X; Mège-Lechevallier F; Comperat E; Ouzzane A; Lemaitre L
Radiology; 2013 Aug; 268(2):461-9. PubMed ID: 23579051
[TBL] [Abstract][Full Text] [Related]
9. Analysis of histological findings obtained combining US/mp-MRI fusion-guided biopsies with systematic US biopsies: mp-MRI role in prostate cancer detection and false negative.
Faiella E; Santucci D; Greco F; Frauenfelder G; Giacobbe V; Muto G; Zobel BB; Grasso RF
Radiol Med; 2018 Feb; 123(2):143-152. PubMed ID: 29019021
[TBL] [Abstract][Full Text] [Related]
10. PSA-density does not improve bi-parametric prostate MR detection of prostate cancer in a biopsy naïve patient population.
Cuocolo R; Stanzione A; Rusconi G; Petretta M; Ponsiglione A; Fusco F; Longo N; Persico F; Cocozza S; Brunetti A; Imbriaco M
Eur J Radiol; 2018 Jul; 104():64-70. PubMed ID: 29857868
[TBL] [Abstract][Full Text] [Related]
11. Which scores need a core? An evaluation of MR-targeted biopsy yield by PIRADS score across different biopsy indications.
Sathianathen NJ; Konety BR; Soubra A; Metzger GJ; Spilseth B; Murugan P; Weight CJ; Ordonez MA; Warlick CA
Prostate Cancer Prostatic Dis; 2018 Nov; 21(4):573-578. PubMed ID: 30038389
[TBL] [Abstract][Full Text] [Related]
12. A prospective study of magnetic resonance imaging and ultrasonography (MRI/US)-fusion targeted biopsy and concurrent systematic transperineal biopsy with the average of 18-cores to detect clinically significant prostate cancer.
Hakozaki Y; Matsushima H; Kumagai J; Murata T; Masuda T; Hirai Y; Oda M; Kawauchi N; Yokoyama M; Homma Y
BMC Urol; 2017 Dec; 17(1):117. PubMed ID: 29233150
[TBL] [Abstract][Full Text] [Related]
13. [Real-time MRI/US fusion-guided biopsy improves detection rates of prostate cancer in pre-biopsied patients].
Maxeiner A; Fischer T; Stephan C; Cash H; Slowinski T; Kilic E; Durmus T
Aktuelle Urol; 2014 May; 45(3):197-203. PubMed ID: 24902069
[TBL] [Abstract][Full Text] [Related]
14. Comparison of systematic transrectal biopsy to transperineal magnetic resonance imaging/ultrasound-fusion biopsy for the diagnosis of prostate cancer.
Borkowetz A; Platzek I; Toma M; Laniado M; Baretton G; Froehner M; Koch R; Wirth M; Zastrow S
BJU Int; 2015 Dec; 116(6):873-9. PubMed ID: 25523210
[TBL] [Abstract][Full Text] [Related]
15. Prostate cancer detection with magnetic resonance-ultrasound fusion biopsy: The role of systematic and targeted biopsies.
Filson CP; Natarajan S; Margolis DJ; Huang J; Lieu P; Dorey FJ; Reiter RE; Marks LS
Cancer; 2016 Mar; 122(6):884-92. PubMed ID: 26749141
[TBL] [Abstract][Full Text] [Related]
16. MR-targeted TRUS prostate biopsy using local reference augmentation: initial experience.
van de Ven WJ; Venderink W; Sedelaar JP; Veltman J; Barentsz JO; Fütterer JJ; Cornel EB; Huisman HJ
Int Urol Nephrol; 2016 Jul; 48(7):1037-45. PubMed ID: 27068817
[TBL] [Abstract][Full Text] [Related]
17. Cognitive MRI-TRUS fusion-targeted prostate biopsy according to PI-RADS classification in patients with prior negative systematic biopsy results.
Lai WJ; Wang HK; Liu HT; Park BK; Shen SH; Lin TP; Chung HJ; Huang YH; Chang YH
J Chin Med Assoc; 2016 Nov; 79(11):618-624. PubMed ID: 27567440
[TBL] [Abstract][Full Text] [Related]
18. Assessment of free-hand transperineal targeted prostate biopsy using multiparametric magnetic resonance imaging-transrectal ultrasound fusion in Chinese men with prior negative biopsy and elevated prostate-specific antigen.
Lian H; Zhuang J; Wang W; Zhang B; Shi J; Li D; Fu Y; Jiang X; Zhou W; Guo H
BMC Urol; 2017 Jul; 17(1):52. PubMed ID: 28679370
[TBL] [Abstract][Full Text] [Related]
19. Combination of prostate imaging reporting and data system (PI-RADS) score and prostate-specific antigen (PSA) density predicts biopsy outcome in prostate biopsy naïve patients.
Washino S; Okochi T; Saito K; Konishi T; Hirai M; Kobayashi Y; Miyagawa T
BJU Int; 2017 Feb; 119(2):225-233. PubMed ID: 26935594
[TBL] [Abstract][Full Text] [Related]
20. Comparison of free-hand transperineal mpMRI/TRUS fusion-guided biopsy with transperineal 12-core systematic biopsy for the diagnosis of prostate cancer: a single-center prospective study in China.
Zhang Q; Wang W; Zhang B; Shi J; Fu Y; Li D; Guo S; Zhang S; Huang H; Jiang X; Zhou W; Guo H
Int Urol Nephrol; 2017 Mar; 49(3):439-448. PubMed ID: 28005230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]